BioCentury
ARTICLE | Company News

Pacific Beach BioSciences Inc, Dong Wha deal

August 20, 2007 7:00 AM UTC

Pacific Beach received exclusive rights to develop and commercialize Dong Wha's zabofloxacin ( PB-101) outside of Australia, New Zealand and certain Asian territories to treat bacterial respiratory in...